Litcius/Paper detail

PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review

Raffaele Ratta, Annalisa Guida, Florian Scotté, Y. Neuzillet, Asmahane Benmaziane Teillet, Thierry Lebrét, Philippe Beuzeboc

2020Prostate Cancer and Prostatic Diseases40 citationsDOI

Topics & Concepts

MedicineProstate cancerOncologyCancerProstateInternal medicinePARP inhibition in cancer therapyProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review | Litcius